SEARCH

SEARCH BY CITATION

References

  • BESSMAN, J.D. & GARDNER, F.H. (1983). Platelet size in thrombocytopenia due to sepsis. Surg. Gynecol. Obstet., 156, 177180.
  • BODE-BÖGER, S.M., BÖGER, R.H., KIENKE, S., JUNKER, W. & FRÖLICH, J.C. (1996). Elevated L-arginine/dimethylarginie ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun., 219, 598603.
  • BÖGER, R.H., BODE-BÖGER, S.M., SYDOW, K., HEISTAD, D.D. & LENTZ, S.R. (2000a). Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol., 20, 15571564.
  • BÖGER, R.H., BODE-BÖGER, S.M., SZUBA, A., TSAO, P.S., CHAN, J.R., TANGPHAO, O., BLASCHKE, T.F. & COOKE, J.P. (1998). Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation, 98, 18421847.
  • BÖGER, R.H., SYDOW, K., BORLAK, J., THUM, T., LENZEN, H., SCHUBERT, B., TSIKAS, D. & BODE-BÖGER, S.M. (2000b). LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res., 87, 99105.
  • CALARA, F., DIMAYUGA, P., NIEMANN, A., THYBERG, J., DICZFALUSY, U., WITZTUM, J.L., PALINSKI, W., SHAH, P.K., CERCEK, B., NILSSON, J. & REGNSTROM, J. (1998). An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler. Thromb. Vasc. Biol., 18, 884893.
  • CHEN, B.M., XIA, L.W. & ZHAO, R.Q. (1997). Determination of NG,NG-dimethylarginine in human plasma by high-performance liquid Chromatography. J. Chromatogr. B. Biomed. Sci. Appl., 692, 467471.
  • DAUGHERTY, A., ZWEIFEL, B.S. & SCHONFELD, G. (1989). Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol., 98, 612618.
  • DUAN, J., MUROHARA, T., IKEDA, H., KATOH, A., SHINTANI, S., SASAKI, K., KAWATA, H., YAMAMOTO, N. & IMAIZUMI, T. (2000). Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation, 102, III370iii376.
  • FENG, Q., LU, X., JONES, D.L., SHEN, J. & ARNOLD, J.M. (2001). Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 104, 700704.
  • FROSTEGARD, J., HAEGERSTRAND, A., GIDLUND, M. & NILSSON, J. (1991). Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis, 90, 119126.
  • FROSTEGARD, J., NILSSON, J., HAEGERSTRAND, A., HAMSTEN, A., WIGZELL, H. & GIDLUND, M. (1990). Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A., 87, 904908.
  • HEGARTY, N.J., YOUNG, L.S., KIRWAN, C.N., O'NEILL, A.J., BOUCHIER-HAYES, D.M., SWEENEY, P., WATSON, R.W. & FITZPATRICK, J.M. (2001). Nitric oxide in unilateral ureteral obstruction: Effect on regional renal blood flow. Kid. Int., 59, 10591065.
  • IGNARRO, L.J., BUGA, G.M., WEI, L.H., BAUER, P.M., WU, G. & DEL SOLDATO, P. (2001). Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. U.S.A., 98, 42024208.
  • ITO, A., TSAO, P.S., ADIMOOLAM, S., KIMOTO, M., OGAWA, T. & COOKE, J.P. (1999). Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation, 99, 30923095.
  • KANEKO, M., HAYASHI, J., SAITO, I. & MIYASAKA, N. (1996). Probucol downregulates E-selectin expression on cultured human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol., 16, 10471051.
  • KITA, T., NAGANO, Y., YOKODE, M., ISHII, K., KUME, N., OOSHIMA, A., YOSHIDA, H. & KAWAI, C. (1987). Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A., 84, 59285931.
  • KOBA, S., PAKALA, R., WATANABE, T., KATAGIRI, T. & BENEDICT, C.R. (2000). Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation. Prostagland. Leukot. Essent. Fatty Acids, 63, 329335.
  • KUGIYAMA, K., KERNS, S.A., MORRISETT, J.D., ROBERTS, R. & HENRY, P.D. (1990). Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature, 344, 160162.
  • KUROSE, I., WOLF, R., GRISHAM, M.B. & GRANGER, D.N. (1995). Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am. J. Physiol., 268, H2224H2231.
  • LEIPER, J. & VALLANCE, P. (1999). Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res., 43, 542548.
  • PARTHASARATHY, S., YOUNG, S.G., WITZUM, J.L., PITTMAN, R.C. & STEINBERG, D. (1986). Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest., 77, 641644.
  • RONG, J.X., RANGASWAMY, S., SHEN, L., DAVE, R., CHANG, Y.H., PETERSON, H., HODIS, H.N., CHISOLM, G.M. & SEVANIAN, A. (1998). Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler. Thromb. Vasc. Biol., 18, 18851894.
  • SIMON, B.C., HANDENSCHILD, C.C. & COHEN, R.A. (1993). Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol., 21, 893901.
  • SURDACKI, A., NOWICKI, M., SANDMANN, J., TSIKAS, D., BÖGER, R.H., BODE-BÖGER, S.M., KRUSZELNICKA-KWIATKOWSKA, O., KOKOT, F., DUBIEL, J.S. & FROELICH, J.C. (1999). Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol., 33, 652658.
  • USUI, M., MATSUOKA, H., MIYAZAKI, H., UEDA, S., OKUDA, S. & IMAIZUMI, T. (1998). Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci., 62, 24252430.
  • VALLANCE, P., LEONE, A., CALVER, A., COLLIER, J. & MONCADA, S. (1992). Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339, 572575.
  • XIONG, Y., LI, Y.J., YU, X.J., LIU, G.Z. & LI, N.S. (1996). Endogenous inhibitor of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits. Zhongguo Yao Li Xue Bao, 17, 149152.
  • YU, X.J., LI, Y.J. & XIONG, Y. (1994). Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci., 54, 753758.
  • ZANETTI, M., KATUSIC, Z.S. & O'BRIEN, T. (2000). Expression and function of recombinant endothelial nitric oxide synthase in human endothelial cells. J. Vasc. Res., 37, 449456.